[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-368910-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-368910-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","computational-pathology-approach-for-assessment-of-prognosis-and-immunotherapy-response-in-pan-gastrointestinal-cancer","Computational pathology approach for assessment of prognosis and immunotherapy response in pan-gastrointestinal cancer","","A computational pathology deep learning pathomics signature (DLPS) is developed to improve cancer prognosis prediction and to identify which patients benefit from chemotherapy and anti–PD-1 immunotherapy in pan-gastrointestinal cancer. This international multicenter study analyzed 2463 patients from twelve cohorts, integrating pathomic features from H&E whole-slide images across nucleus, tumor microenvironment, and single-cell spatial distribution scales. The DLPS showed significant association with overall survival, improved risk stratification beyond TNM, and revealed differential treatment benefits.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/computational-pathology-approach-for-assessment-of-prognosis-and-immunotherapy-response-in-pan-gastrointestinal-cancer/368910/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/computational-pathology-approach-for-assessment-of-prognosis-and-immunotherapy-response-in-pan-gastrointestinal-cancer/368910.png","ImageObject",300,407,{"name":42,"@type":43},"Fans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in current cancer staging?","Question",{"text":63,"@type":64},"Current staging methods cannot accurately predict survival outcomes and therapeutic benefits, leading to limited guidance for prognosis and treatment selection.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the DLPS developed and what data were used?",{"text":68,"@type":64},"The DLPS was built from deep learning pathomics features integrated across three scales from H&E whole-slide images, including nucleus-related features, tumor microenvironment features, and single-cell spatial distribution.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the key findings about prognosis and treatment response?",{"text":72,"@type":64},"The DLPS was significantly associated with overall survival and acted as an independent prognostic factor; the nomogram combining DLPS with TNM improved predictive performance. Low-DLPS patients showed greater benefit from adjuvant chemotherapy and had a higher objective response rate to anti–PD-1 immunotherapy than high-DLPS patients.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},368910,1790445304,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},5909892330395,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Zhang et al. Journal of Translational Medicine (2025) 23:1088  \n[https://doi.org/10.1186/s12967-025-06181-3](https://doi.org/10.1186/s12967-025-06181-3)  \nJournal of Translational Medicine  \n RESEARCH Open Access  \nComputational pathology approach for assessment of prognosis and immunotherapy response in pan-gastrointestinal cancer  \nTaojun Zhang1†, Zepang Sun1†, Zhe Li2†, M. Usman Ahmad3, Md Tauhidul Islam2, Fan Yang4, Xianqi Yang5, Lin Wu6, Jingjing Xie7, Wanying Feng8, Yan Chen9, Alyssa A. Guo 10, Guoxin Li1, Wei Wang5, Jiang Yu1*†, Zhenhui Li11*† andYuming Jiang12*†  \nAbstract  \nBackground Current cancer staging methods cannot accurately predict survival outcomes and therapeutic benefits in cancer patients. Digital pathomics, a rapidly evolving field, holds significant potential to revolutionize disease evaluation.  \nMethods This international multicenter study included 2463 patients with pan-gastrointestinal cancer from twelve cohorts of seven cancer centers, of whom 1653 patients were diagnosed with gastric cancer (GC) . We proposed a deep learning pathomics signature (DLPS) by integrating information on three scales from the whole slide images (WSIs) of H&E-stained tissue, including pathomic features related to the nucleus, microenvironment, and single-cell spatial distribution. Next, we assessed the predictive accuracy ofthe DLPS for prognosis, chemotherapy response, and immunotherapy response.  \nResults Our findings revealed that the DLPS was significantly associated with overall survival in gastric cancer (GC) and pan-gastrointestinal cancers, exhibiting good accuracy with area under the curve values ranging from 0.723 to 0.840 across GC cohorts. Multivariable Cox regression analyses indicated that the DLPS is an independent prognostic factor. The nomogram that integrated the DLPS and TNM stage showed improved performance in predicting cancer prognosis compared to that with TNM stage alone (P \u003C 0. 05) . Importantly, GC patients with low-DLPS (but not those with high-DLPS) exhibited substantial benefits from adjuvant chemotherapy (P \u003C 0. 05) . Furthermore, the objective response rate to anti-PD-1 immunotherapy was significantly higher in the low-DLPS group (29 . 6%) compared to the high-DLPS group (8 . 3%, P \u003C 0. 05) .  \n\n| †Taojun Zhang, Zepang Sun and Zhe Li contributed equally as first authors. |\n| --- |\n| †Jiang Yu, Zhenhui Li andYuming Jiang contributed equally as senior authors. |\n\n*Correspondence: Jiang Yu [balbc@163.com](balbc@163.com)[ ](balbc@163.com)Zhenhui Li  \n[lizhenhui@kmmu.edu.cn](lizhenhui@kmmu.edu.cn)[ ](lizhenhui@kmmu.edu.cn)Yuming Jiang [yumjiang@wakehealth.edu](yumjiang@wakehealth.edu)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nZhang et al. Journal of Translational Medicine (2025) 23:1088 Page 2 of 18  \nConclusions The DLPS has the p","cbCaip6V4kAvdtzy","https://ap.wps.com/l/cbCaip6V4kAvdtzy","pdf",6383824,18,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Gastric cancer burden and limitations of TNM\n## Immunotherapy heterogeneity and need for patient selection\n## Biomarkers and limitations\n## Advances in tumor marker technologies","[{\"question\":\"What problem does the study address in current cancer staging?\",\"answer\":\"Current staging methods cannot accurately predict survival outcomes and therapeutic benefits, leading to limited guidance for prognosis and treatment selection.\"},{\"question\":\"How was the DLPS developed and what data were used?\",\"answer\":\"The DLPS was built from deep learning pathomics features integrated across three scales from H\\u0026E whole-slide images, including nucleus-related features, tumor microenvironment features, and single-cell spatial distribution.\"},{\"question\":\"What were the key findings about prognosis and treatment response?\",\"answer\":\"The DLPS was significantly associated with overall survival and acted as an independent prognostic factor; the nomogram combining DLPS with TNM improved predictive performance. Low-DLPS patients showed greater benefit from adjuvant chemotherapy and had a higher objective response rate to anti–PD-1 immunotherapy than high-DLPS patients.\"}]","Computational pathology approach for assessment of prognosis and immunotherapy response in pan-gastrointestinal cancer | PDF",1790179181,45,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/10edfee0b88e5bf253a199da18dad87d.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89b6d259517b0853fd0e61c10a259ca1.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff6971e7dcca679b3b3338c9337ee0fc.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/85a6b28f639b5970647416ead628d9fc.webp",980,1301]